 Toan Ong
Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Record Linkage | 4 | 2023 | 53 | 1.460 |
Why?
| | Hospitalization | 19 | 2023 | 1750 | 1.000 |
Why?
| | Electronic Health Records | 4 | 2023 | 800 | 0.960 |
Why?
| | Immunization, Secondary | 3 | 2022 | 82 | 0.870 |
Why?
| | Heart Defects, Congenital | 4 | 2020 | 671 | 0.770 |
Why?
| | Influenza Vaccines | 5 | 2023 | 497 | 0.740 |
Why?
| | Population Surveillance | 2 | 2020 | 392 | 0.700 |
Why?
| | Influenza, Human | 4 | 2023 | 546 | 0.570 |
Why?
| | Ambulatory Care | 6 | 2023 | 478 | 0.570 |
Why?
| | Data Mining | 1 | 2017 | 100 | 0.540 |
Why?
| | Medical Informatics | 1 | 2014 | 90 | 0.420 |
Why?
| | Emergency Service, Hospital | 11 | 2023 | 1815 | 0.400 |
Why?
| | Biomedical Research | 2 | 2017 | 585 | 0.400 |
Why?
| | Outpatients | 3 | 2022 | 326 | 0.380 |
Why?
| | Adult | 26 | 2023 | 30543 | 0.360 |
Why?
| | Critical Illness | 2 | 2023 | 644 | 0.300 |
Why?
| | United States | 16 | 2023 | 12180 | 0.300 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2020 | 2094 | 0.270 |
Why?
| | Vaccines, Combined | 5 | 2023 | 46 | 0.270 |
Why?
| | Adolescent | 17 | 2023 | 17838 | 0.270 |
Why?
| | Humans | 38 | 2023 | 114655 | 0.260 |
Why?
| | Vaccines, Synthetic | 5 | 2022 | 124 | 0.240 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2020 | 3252 | 0.230 |
Why?
| | RNA, Messenger | 7 | 2023 | 2552 | 0.220 |
Why?
| | Viral Vaccines | 1 | 2023 | 88 | 0.200 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2023 | 139 | 0.190 |
Why?
| | Information Dissemination | 1 | 2023 | 186 | 0.190 |
Why?
| | Aged, 80 and over | 5 | 2022 | 6345 | 0.180 |
Why?
| | Algorithms | 2 | 2020 | 1467 | 0.170 |
Why?
| | Immunocompromised Host | 1 | 2021 | 195 | 0.170 |
Why?
| | India | 4 | 2020 | 134 | 0.170 |
Why?
| | Information Storage and Retrieval | 1 | 2020 | 106 | 0.160 |
Why?
| | Probability | 1 | 2020 | 289 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 288 | 0.160 |
Why?
| | Middle Aged | 10 | 2023 | 26733 | 0.150 |
Why?
| | Aged | 8 | 2023 | 19069 | 0.150 |
Why?
| | Vaccination | 5 | 2023 | 1204 | 0.150 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 159 | 0.150 |
Why?
| | Male | 15 | 2023 | 55580 | 0.140 |
Why?
| | Young Adult | 9 | 2022 | 10466 | 0.140 |
Why?
| | Female | 15 | 2023 | 59489 | 0.140 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 221 | 0.140 |
Why?
| | Comparative Effectiveness Research | 1 | 2017 | 130 | 0.140 |
Why?
| | Databases, Factual | 2 | 2019 | 1125 | 0.130 |
Why?
| | Colorado | 3 | 2020 | 4099 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2023 | 3003 | 0.130 |
Why?
| | Hospital Mortality | 3 | 2023 | 776 | 0.120 |
Why?
| | Research Design | 2 | 2023 | 928 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 515 | 0.110 |
Why?
| | Registries | 4 | 2020 | 1767 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1262 | 0.100 |
Why?
| | Child | 8 | 2023 | 18407 | 0.100 |
Why?
| | Laboratories | 2 | 2021 | 95 | 0.090 |
Why?
| | Child, Preschool | 4 | 2023 | 9111 | 0.070 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2023 | 40 | 0.050 |
Why?
| | RNA, Messenger, Stored | 1 | 2022 | 12 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2023 | 63 | 0.050 |
Why?
| | Stakeholder Participation | 1 | 2023 | 73 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 122 | 0.050 |
Why?
| | Treatment Failure | 1 | 2022 | 331 | 0.050 |
Why?
| | Seasons | 1 | 2023 | 442 | 0.050 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 22 | 0.040 |
Why?
| | Immunization Schedule | 1 | 2021 | 184 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 359 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 280 | 0.040 |
Why?
| | Ambulatory Care Facilities | 1 | 2021 | 213 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2020 | 5044 | 0.040 |
Why?
| | Demography | 1 | 2020 | 260 | 0.040 |
Why?
| | Bias | 1 | 2020 | 179 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 581 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 446 | 0.040 |
Why?
| | Linear Models | 1 | 2019 | 768 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 617 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2022 | 645 | 0.030 |
Why?
| | Infant | 2 | 2020 | 7959 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1078 | 0.030 |
Why?
| | Patient Readmission | 1 | 2021 | 610 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 599 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2312 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2250 | 0.030 |
Why?
| | Cohort Studies | 1 | 2023 | 4895 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3327 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4411 | 0.020 |
Why?
| | Time Factors | 1 | 2022 | 6115 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5517 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2508 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9088 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2020 | 12545 | 0.010 |
Why?
|
|
Ong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|